Antimicrobial potentiality of a new non-antibiotic: The cardiovascular drug oxyfedrine hydrochloride

Kaushiki Mazumdar, Kumkum Ganguly, K. Asok Kumar, N. K. Dutta, A. N. Chakrabarty, Sujata G. Dastidar

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Ten cardiovascular drugs, having diverse pharmacological action, were screened for possible antimicrobial property against known eight sensitive bacteria, belonging to Gram positive and Gram negative types. Although five drugs failed to show antimicrobial activity and three had moderate antimicrobial action, oxyfedrine HCl and dobutamine were seen to possess pronounced antimicrobial property. Oxyfedrine was further tested in vitro against 471 strains of bacteria from two Gram positive and fourteen Gram negative genera. The minimum inhibitory concentration (MIC) of oxyfedrine was determined by agar dilution method, which ranged from 50-200 μg/ml in most of the strains, while some strains were inhibited at even lower concentrations. In animal experiments, this compound was capable of offering significant protection to Swiss strain of white mice, challenged with 50 median lethal dose (MLD) of a virulent strain of Salmonella typhimurium at concentrations of 15, 30 and 60 μg/mouse. The in vivo results were highly significant according to chi-square test.

Original languageEnglish (US)
Pages (from-to)259-264
Number of pages6
JournalMicrobiological Research
Issue number3
StatePublished - 2003


  • Antimicrobial activity
  • Antimicrobic
  • Cardiovascular drug
  • Non antibiotic
  • Oxyfedrine

ASJC Scopus subject areas

  • Microbiology


Dive into the research topics of 'Antimicrobial potentiality of a new non-antibiotic: The cardiovascular drug oxyfedrine hydrochloride'. Together they form a unique fingerprint.

Cite this